Question Everything. See who's reporting it.

FDA clears Roche’s Alzheimer’s blood test for U.S. use

Source: The Straits Times

The story in brief

The FDA has cleared Roche's Elecsys pTau217 blood test for Alzheimer’s disease, following its European approval in May. The test, which identifies potential Alzheimer’s-related brain changes, will be offered by Labcorp and Quest Diagnostics, expanding U.S. access. It can run on existing Roche analysers, offering a simpler alternative to costly and invasive current methods like PET scans and cerebrospinal fluid testing.

NEWXFree on Android and iPhone. Open in NEWX